This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New York Court Of Appeals Rejects Claim For Medical Monitoring

The New York Court of Appeals today said that New York law does not allow for an independent cause of action for medical monitoring. The U.S. Court of Appeals for the Second Circuit asked the state’s highest court to decide whether current or former long-term smokers who have no sign of disease can pursue an independent claim against a tobacco company to establish a medical monitoring program.

"We believe that the New York Court of Appeals correctly held that there is no basis under the law that supports creating a medical monitoring claim,” said Murray Garnick, Altria Client Services senior vice president and associate general counsel, speaking on behalf of Philip Morris USA. “In so ruling, the New York Court of Appeals has joined with many courts throughout the country in rejecting such a sweeping new cause of action.”

In its decision, the court said, “Allowance of such a claim, absent any evidence of present physical injury or damage to property, would constitute a significant deviation from our tort jurisprudence.”

In declining to create a new cause of action, the court expressed serious concerns about the “potential systemic effects of creating a new, full-blown tort law cause of action.” The court concluded that creating a medical monitoring cause of action could result in “effectively flooding the courts” and noted that “there is no framework concerning how such a medical monitoring program would be implemented and administered.”

In 2011, a federal district court ruled that there was no legal basis for claims made by plaintiffs in Caronia requesting that the company pay for annual low-dose CT scans for long-term smokers to determine whether they have lung cancer. The trial court dismissed the lawsuit finding that plaintiffs' claims were legally invalid.

This case is Caronia v. Philip Morris USA, Inc.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,790.24 +170.73 0.97%
S&P 500 2,072.55 +9.44 0.46%
NASDAQ 5,028.3450 +41.4780 0.83%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs